FDA Drug Application (012026) for APRESOLINE-ESIDRIX by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number012026
Product Number002
FormTABLET;ORAL
Dosage25MG;15MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAPRESOLINE-ESIDRIX
Active IngredientHYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE



Back to FDA Applications sponsored by NOVARTIS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.